Global Clinical Research, Quality and Regulatory Consulting Services

Established CRO with Clinical, Quality and Regulatory consulting services and solutions for In Vitro Diagnostics, Medical Devices, and Biopharmaceuticals.

Learn More

OUR SPECIALTIES

Landrich Group specializes in advancing In Vitro Diagnostics, Medical Devices,

Companion Diagnostics, Clinical Quality Assurance, and Biopharma through

Clinical Research, Quality, and Regulatory consulting services.

In Vitro
Diagnostics

Companion
Diagnostics

Medical Devices

Biopharma

Clinical Quality Assurance

OUR SERVICES

U.S. AGENT

MEET THE FOUNDERS

Tina Landess

Dave Petrich

Meet the Team

Hal Mann, MBA

Former Sr. Director, Clinical Operations at Roche Diagnostics

"I worked closely with the Landrich Group to strengthen Clinical Operations at Roche Diagnostics, particularly within our inspection readiness program for a few high-visibility, CRO-outsourced trials. Their deep clinical operational, quality, and regulatory expertise—combined with their ability to rapidly understand the nuances of complex diagnostic and device trials—made a significant impact on our organization. Landrich’s mock audit process was exceptionally thorough, practical, and solution-oriented. Their team provided clear, actionable guidance that not only strengthened our documentation and vendor oversight practices but also elevated our internal teams’ confidence ahead of health authority inspections. Their proactive insights helped us identify risks early, streamline cross-functional alignment, and reinforce a culture of inspection readiness across multiple programs. We especially valued their responsiveness, clarity, and ability to partner seamlessly with both internal teams and CRO counterparts. Thanks to their disciplined approach and strategic recommendations, we improved operational quality, reduced inspection-related risks, and enhanced our overall state of compliance. I highly recommend the Landrich Group for any organization seeking expert support across clinical operations, vendor oversight, quality systems, and regulatory preparedness."